Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Resolving phenotypic and prognostic differences in interstitial lung disease related to systemic sclerosis by computed tomography-based radiomics

J. Schniering, M. Maciukiewicz, H. S. Gabrys, M. Brunner, C. Blüthgen, C. Meier, S. Braga-Lagache, A. Uldry, M. Heller, O. Distler, M. Guckenberger, H. Fretheim, A. Hoffmann-Vold, C. T. Nakas, T. Frauenfelder, S. Tanadini-Lang, B. Maurer
doi: https://doi.org/10.1101/2020.06.09.20124800
J. Schniering
1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Maciukiewicz
1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. S. Gabrys
2Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Brunner
1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Blüthgen
3Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Meier
1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Braga-Lagache
4Proteomics and Mass Spectrometry Core Facility, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Uldry
4Proteomics and Mass Spectrometry Core Facility, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Heller
4Proteomics and Mass Spectrometry Core Facility, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
O. Distler
1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Guckenberger
2Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Fretheim
5Department of Rheumatology, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Hoffmann-Vold
5Department of Rheumatology, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. T. Nakas
6Laboratory of Biometry, University of Thessaly, Volos, Greece
7University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Frauenfelder
3Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Tanadini-Lang
2Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Maurer
1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: britta.maurer@usz.ch
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Radiomic features are quantitative data calculated from routine medical images and have shown great potential for disease phenotyping and risk stratification in cancer. Patients with systemic sclerosis (SSc), a multi-organ autoimmune disorder, have a similarly poor prognosis (10-year survival of 66%), due to interstitial lung disease (ILD) as the primary cause of death. Here, we present the analysis of 1,355 stable radiomic features extracted from computed tomography scans from 156 SSc-ILD patients, which describe distinct disease phenotypes and show prognostic power in two independent cohorts. We derive and externally validate a first quantitative radiomic risk score, qRISSc that accurately predicts progression-free survival in SSc-ILD and outperforms current clinical stratification measures. Correlation analysis with lung proteomics, histology and gene expression data in a cross-species approach demonstrates that qRISSc reverse translates into mice and captures the fibrotic remodeling process in experimental ILD.

Competing Interest Statement

J.S., M.M., H.S.G, M.B., C.M., C.B., M.G., S.B., A.U., M.H., C.T.N., T.F, S.T. have no competing interests to declare. O.D. had consultancy relationship and/or has received research funding from Abbvie, Actelion, Acceleron Pharma, Amgen, AnaMar, Baecon Discovery, Blade Therapeutics, Bayer, Boehringer Ingelheim, Catenion, Competitive Drug Development International Ltd, CSL Behring, ChemomAb, Curzion Pharmaceuticals, Ergonex, Galapagos NV, Glenmark Pharmaceuticals, GSK, Inventiva, Italfarmaco, iQone, iQvia, Lilly, medac, Medscape, Mitsubishi Tanabe Pharma, MSD, Novartis, Pfizer, Roche, Sanofi, Target Bio Science and UCB in the area of potential treatments of scleroderma and its complications. In addition, O.D. has a patent mir-29 for the treatment of systemic sclerosis issued (US8247389, EP2331143). H.F. received travel bursaries from Actelion and GSK, and remuneration from Bayer. A.M.H.V had grant/research support from Boehringer-Ingelheim and received speaker and personal fees from Boehringer-Ingelheim, Roche, Actelion, and Bayer. B. M. had grant/research support from AbbVie, Protagen, Novartis Biomedical Research as well as congress support from Pfizer, Roche, Actelion, and MSD. In addition, B.M. has a patent mir-29 for the treatment of systemic sclerosis registered (US8247389, EP2331143). This work was supported by the Forschungskredit PostDoc from University of Zurich (to J.S.; FK-19-046), the Bangerter Foundation and Swiss Academy of Medical Sciences (to C.M.), as well as the Gebauer Foundation, Lunge Zurich Foundation, OPO Foundation, and Prof. Max Cloetta Foundation (to B.M.).

Funding Statement

This work was supported by the Forschungskredit PostDoc from University of Zurich (to J.S.; FK-19-046), the Bangerter Foundation and Swiss Academy of Medical Sciences (to C.M.), as well as the Gebauer Foundation, Lunge Zurich Foundation, OPO Foundation, and Prof. Max Cloetta Foundation (to B.M.).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the local ethics committees (approval numbers: pre-BASEC-EK-839 (KEK-no.-2016-01515), KEK-ZH-no. 2010-158/5, BASEC-no. 2018-02165) and written informed consent was obtained from every patient.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

For data and material requests please contact the corresponding author (britta.maurer{at}usz.ch).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 09, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Resolving phenotypic and prognostic differences in interstitial lung disease related to systemic sclerosis by computed tomography-based radiomics
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Resolving phenotypic and prognostic differences in interstitial lung disease related to systemic sclerosis by computed tomography-based radiomics
J. Schniering, M. Maciukiewicz, H. S. Gabrys, M. Brunner, C. Blüthgen, C. Meier, S. Braga-Lagache, A. Uldry, M. Heller, O. Distler, M. Guckenberger, H. Fretheim, A. Hoffmann-Vold, C. T. Nakas, T. Frauenfelder, S. Tanadini-Lang, B. Maurer
medRxiv 2020.06.09.20124800; doi: https://doi.org/10.1101/2020.06.09.20124800
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Resolving phenotypic and prognostic differences in interstitial lung disease related to systemic sclerosis by computed tomography-based radiomics
J. Schniering, M. Maciukiewicz, H. S. Gabrys, M. Brunner, C. Blüthgen, C. Meier, S. Braga-Lagache, A. Uldry, M. Heller, O. Distler, M. Guckenberger, H. Fretheim, A. Hoffmann-Vold, C. T. Nakas, T. Frauenfelder, S. Tanadini-Lang, B. Maurer
medRxiv 2020.06.09.20124800; doi: https://doi.org/10.1101/2020.06.09.20124800

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Respiratory Medicine
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (451)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5263)
  • Forensic Medicine (3)
  • Gastroenterology (196)
  • Genetic and Genomic Medicine (758)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (699)
  • Health Policy (360)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (163)
  • Infectious Diseases (except HIV/AIDS) (5881)
  • Intensive Care and Critical Care Medicine (363)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (766)
  • Nursing (43)
  • Nutrition (131)
  • Obstetrics and Gynecology (143)
  • Occupational and Environmental Health (234)
  • Oncology (479)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (98)
  • Psychiatry and Clinical Psychology (863)
  • Public and Global Health (2017)
  • Radiology and Imaging (349)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (286)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)